RecruitingPhase 2NCT07752979
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Sponsor: AbbVie
Amarillo, TX · Austin, TX · Bellaire, TX · +56 more sites
Clinical trials in Longview, TX
9 recruiting studies have a site in or near Longview, TX, Texas.
Top conditions here
- Obesity (3)
- Lung Cancer (2)
- Type 1 Diabetes (2)
- Heart Failure (1)
- Colorectal Cancer (1)
- Schizophrenia (1)
- Type 2 Diabetes (1)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 9 of 9 studies
RecruitingPhase 3NCT06935370
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Sponsor: Boehringer Ingelheim
Amarillo, TX · Beaumont, TX · +86 more sites
RecruitingPhase 3NCT07144280
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Sponsor: Pfizer
Abilene, TX · Allen, TX · Amarillo, TX · +238 more sites
RecruitingPhase 3NCT07222566
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Sponsor: Pfizer
Abilene, TX · Allen, TX · Amarillo, TX · +223 more sites
RecruitingPhase 3NCT07222800
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Sponsor: Pfizer
Abilene, TX · Amarillo, TX · Beaumont, TX · +251 more sites
RecruitingPhase 3NCT07794579
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Sponsor: Eli Lilly and Company
Austin, TX · Brownsville, TX · Dallas, TX · +77 more sites
RecruitingPhase not listedNCT07101094
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
Sponsor: Bristol-Myers Squibb
El Paso, TX · Longview, TX · +18 more sites
RecruitingPhase 3NCT07564414
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Sponsor: Novo Nordisk A/S
Amarillo, TX · Austin, TX · +96 more sites
RecruitingPhase 3NCT07797335
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Sponsor: Novo Nordisk A/S
Amarillo, TX · Austin, TX · Conroe, TX · +106 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.